Nautilus Biotechnology, Inc. (NAUT)

2.06 -0.16 (-7.21%) USD  |  NASDAQ  |  Jan 09, 16:00
2.05 -0.01 (-0.49%) Pre-Market: 08:54
More

Nautilus Biotechnology Total Expenses (Quarterly)

Total Expenses (Quarterly) Chart

View Total Expenses (Quarterly) for NAUT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (Quarterly) Range, Past 5 Years

View Total Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Quarterly) Benchmarks

View Total Expenses (Quarterly) Benchmarks
Start Trial
Sensus Healthcare, Inc. Upgrade
GoodRx Holdings, Inc. Upgrade
Prelude Therapeutics, Inc. Upgrade
ProKidney Corp. Upgrade
Neumora Therapeutics, Inc. Upgrade

Total Expenses (Quarterly) Related Metrics

Net Income (Quarterly) Upgrade
EPS Diluted (Quarterly) Upgrade
Enterprise Value Upgrade
Earnings Yield Upgrade
Normalized Earnings Yield Upgrade